KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Amortization - Intangibles (2016 - 2025)

Biogen has reported Amortization - Intangibles over the past 17 years, most recently at $136.6 million for Q4 2025.

  • Quarterly results put Amortization - Intangibles at $136.6 million for Q4 2025, down 9.66% from a year ago — trailing twelve months through Dec 2025 was $515.0 million (up 15.29% YoY), and the annual figure for FY2025 was $515.0 million, up 15.29%.
  • Amortization - Intangibles for Q4 2025 was $136.6 million at Biogen, up from $135.7 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for BIIB hit a ceiling of $604.1 million in Q2 2021 and a floor of $50.2 million in Q1 2023.
  • Median Amortization - Intangibles over the past 5 years was $92.5 million (2021), compared with a mean of $122.5 million.
  • Biggest five-year swings in Amortization - Intangibles: skyrocketed 882.28% in 2021 and later tumbled 88.83% in 2022.
  • Biogen's Amortization - Intangibles stood at $68.1 million in 2021, then soared by 156.98% to $175.0 million in 2022, then crashed by 56.23% to $76.6 million in 2023, then skyrocketed by 97.39% to $151.2 million in 2024, then dropped by 9.66% to $136.6 million in 2025.
  • The last three reported values for Amortization - Intangibles were $136.6 million (Q4 2025), $135.7 million (Q3 2025), and $130.9 million (Q2 2025) per Business Quant data.